NCT07296822 Internet-Based Cognitive Behavioral Therapy for MRI-Related Anxiety
| NCT ID | NCT07296822 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Johan Kihlberg |
| Condition | Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-05-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to investigate whether internet-based cognitive behavioural therapy (iCBT) can help patients who have difficulty undergoing magnetic resonance imaging (MRI). The main question to be answered is \- Can patients undergo MRI with less anxiety using iCBT? The patients will undergo a four-week treatment that includes information about MRI, anxiety management, relaxation and retention. The end goal is to simulate an MRI scan in a mock scanner where participants can report their anxiety. Half of the participants will be randomized to receive the treatment before (intervention group) the simulated MRI scan and half will receive the treatment after the simulated MRI scan (control group). Up to 60 patients will be included plus some pilot patients.
Eligibility Criteria
Inclusion Criteria: * self-perceived problems with doing MRI examinations Exclusion Criteria: * difficulty understanding written text * severe mental health problems
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07296822 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07296822 currently recruiting?
Yes, NCT07296822 is actively recruiting participants. Contact the research team at johan.kihlberg@liu.se for enrollment information.
Where is the NCT07296822 trial being conducted?
This trial is being conducted at Linköping, Sweden.
Who is sponsoring the NCT07296822 clinical trial?
NCT07296822 is sponsored by Johan Kihlberg. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.